Dipika Gemani
About Dipika Gemani
Dipika Gemani is a Scientist II currently employed at Prothena Corporation plc since 2021. She has extensive experience in research and development, having previously worked at notable organizations such as Quanterix, Biogen, and the University of Maryland School of Medicine.
Current Role at Prothena Corporation
Dipika Gemani has been serving as a Scientist II at Prothena Corporation plc since 2021. In this role, she contributes to the company's research and development efforts, focusing on advancing therapeutic solutions. Her position involves applying her scientific expertise to support various projects within the organization.
Previous Experience at Quanterix
Dipika Gemani worked at Quanterix from 2013 to 2018, holding multiple roles including Senior Research Associate and Technical Application Scientist. During her four years as a Senior Research Associate, she focused on developing and optimizing assays. She later transitioned to the role of Technical Application Scientist, where she provided technical support and application expertise.
Educational Background in Bioinformatics
Dipika Gemani earned her Bachelor of Technology in Bioinformatics from the University of Mumbai, studying from 2003 to 2007. She furthered her education by obtaining a Master of Science in Molecular Medicine from the University of Maryland Baltimore, completing her studies from 2007 to 2010. This educational foundation has equipped her with a strong understanding of biological data analysis and research methodologies.
Research Experience at University of Maryland
Dipika Gemani's research experience includes working at the University of Maryland School of Medicine, where she held positions as a Research Assistant and Laboratory Technician from 2008 to 2010. In these roles, she engaged in various research projects, contributing to the advancement of medical knowledge and techniques.
Professional Journey in the Biotech Industry
Dipika Gemani has built a diverse career in the biotech industry, with roles at Biogen and Meso Scale Discovery. At Biogen, she served as an Assay Development Scientist from 2018 to 2020, focusing on developing assays for drug discovery. Prior to that, she worked as a Research Associate at Meso Scale Discovery from 2010 to 2012, where she contributed to research initiatives.